Related Experiment Video
Updated: Aug 25, 2026
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Novel therapies
Douglas E Peterson1, Susan L Beck, Dorothy M K Keefe
1Department of Oral Diagnosis, School of Dental Medicine, University of Connecticut Health Center, Farmington 06030-1605, USA.
Objective:
To highlight selected research directed to new drug and device technologies to manage mucositis in cancer patients and to illustrate potential impact of successful therapies.
Data Sources:
Published research articles and abstracts, clinical experience.
Conclusion:
Advances in molecular modeling of mucosal injury in cancer patients have created new opportunities for therapy. Research is analyzing the impact of single-agent interventions; varying degrees of efficacy are being reported. Once optimal dosing strategies for single-agent management are defined, the opportunity for multi-agent therapies will emerge.
Implications For Nursing Practice:
The oncology nurse plays a pivotal role in assessing and managing mucositis in cancer patients.
Insights
New drug and device technologies show promise for managing cancer patient mucositis. Future research will explore multi-agent therapies, with oncology nurses crucial for patient care.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Mucositis is a debilitating side effect of cancer treatment.
- Current management strategies for mucositis have limitations.
- Advances in understanding mucosal injury offer new therapeutic avenues.
Purpose of the Study:
- To review emerging drug and device technologies for managing cancer patient mucositis.
- To assess the potential impact of novel mucositis therapies.
- To highlight the role of molecular modeling in developing new treatments.
Main Methods:
- Review of published research articles and abstracts.
- Inclusion of clinical experience.
- Focus on molecular modeling of mucosal injury.
Main Results:
- Single-agent interventions are being investigated with varying efficacy.
- Molecular modeling advances are creating new therapeutic opportunities.
- Research indicates a need for further investigation into optimal dosing.
Conclusions:
- Novel drug and device technologies hold promise for improved mucositis management.
- Development of multi-agent therapies is a future direction.
- Oncology nurses are essential in assessing and managing mucositis.
Related Concept Videos
01:28Drug Therapy
Antianxiety Medications
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...